When Language Hurts Scientists And Their Employers

Sajal Das started out well. A bright boy from Calcutta, he finished his undergraduate degree in India, earned a Ph.D. studying high-temperature polymers at North Carolina State University, and soon found a good R&D job at Morristown, N.J. -based Allied-Signal Corp. But then he stalled. While his United States-born colleagues went scampering up the corporate-scientific ladder, Das has stayed put, although, in his opinion, his science is every bit as good as anyone’s. The trouble, from wh

Written byPhil Garber
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

But then he stalled. While his United States-born colleagues went scampering up the corporate-scientific ladder, Das has stayed put, although, in his opinion, his science is every bit as good as anyone’s. The trouble, from what he has been able to gather, is his English: Although Das is easy to understand in conversation—he has been speaking English since he was a young boy—he has been told that his written reports sound awkward and contain grammatical mistakes.

Das is one of a growing number of foreign-born scientists and engineers who are recruited by U.S. companies—only to slam into the language barrier of corporate English. It bruises them, and as their numbers rise, the collisions could bruise the companies that hire them, as well. Recognizing this potential liability, a number of forward-looking organizations around the country are setting up formal tutoring programs to teach foreign-born scientists and engineers the basics of business ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies